Florian Castet
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
Papers in
- Co-authors
- Josep Maria Llovet (3 shared papers)David James Pinato (1 shared paper)Richard S. Finn (1 shared paper)Eli Pikarsky (1 shared paper)Andrew Xiuxuan Zhu (1 shared paper)Mathias Heikenwalder (1 shared paper)Mala K. Maini (1 shared paper)Vincenzo Mazzaferro (1 shared paper)
- Journals
- Liver International (4 papers)Annals of Oncology (3 papers)European Journal of Cancer (3 papers)Clinical Cancer Research (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- SpainItalyUnited States
In The Last Decade
Florian Castet
32 papers receiving 3.0k citations
Florian Castet's Hit Papers
Peers
Comparison fields: 5 of 83
- Hepatology 1.1k
- Cancer Research 430
- Oncology 755
- Immunology 487
- Epidemiology 559
Countries citing papers authored by Florian Castet
This map shows the geographic impact of Florian Castet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Castet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Castet more than expected).
Fields of papers citing papers by Florian Castet
This network shows the impact of papers produced by Florian Castet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Castet. The network helps show where Florian Castet may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Castet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunotherapies for hepatocellular carcinoma Hit paper breakdown → | 2021 | 1335 |
| 2 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC Hit paper breakdown → | 2021 | 1006 |
| 3 | Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020) Hit paper breakdown → | 2021 | 204 |
| 4 | Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification Hit paper breakdown → | 2022 | 186 |
| 5 | 2022 | 115 | |
| 6 | 2019 | 46 | |
| 7 | 2024 | 30 | |
| 8 | 2022 | 20 | |
| 9 | 2019 | 19 | |
| 10 | 2024 | 19 | |
| 11 | 2023 | 18 | |
| 12 | 2021 | 17 | |
| 13 | 2018 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2022 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2024 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2023 | 2 |
About Florian Castet
Florian Castet is a scholar working on Surgery, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (22 papers), Pancreatic and Hepatic Oncology Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer Mechanisms and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Genomics and Diagnostics (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (430 citations), Oncology (755 citations), Immunology (487 citations) and Epidemiology (559 citations). Florian Castet has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Josep Maria Llovet, David James Pinato, Richard S. Finn, Eli Pikarsky, Andrew Xiuxuan Zhu, Mathias Heikenwalder, Mala K. Maini, Vincenzo Mazzaferro, Philipp Konstantin Haber and Myron Schwartz. Their work appears in journals such as Liver International, Annals of Oncology, European Journal of Cancer, Clinical Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.